Literature DB >> 11972630

Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells.

Huazhang An1, Yizhi Yu, Minghui Zhang, Hongmei Xu, Runzi Qi, Xiaoyi Yan, Shuxun Liu, Wenya Wang, Zhenghong Guo, Jun Guo, Zhihai Qin, Xuetao Cao.   

Abstract

Toll-like receptors (TLR) are sentinel receptors capable of recognizing pathogen-associated molecule patterns (PAMP) such as lipopolysaccharide (LPS) and CpG-containing oligonucleotides (CpG ODN). TLR2 and TLR4 are major receptors for Gram-positive and Gram-negative bacterial cell wall components, respectively. TLR9 is necessary for CpG signalling. LPS or CpG ODN can activate immature dendritic cells (DC) and induce DC maturation characterized by production of cytokines, up-regulation of co-stimulatory molecules, and increased ability to activate T cells. However, little is known regarding the regulation of TLR gene expression in mouse DC. In this study, we investigated the regulation of TLR2, TLR4 and TLR9 gene expression by LPS in murine immature DC. TLR2, TLR4 and TLR9 mRNA were up-regulated following LPS stimulation. The up-regulation of TLR9 expression coincided with significantly increased production of tumour necrosis factor-alpha induced by LPS plus CpG ODN. While inhibition of extracellular signal-related kinase and NF-kappaB activation suppressed the up-regulation of the expression of TLR2, TLR4 and TLR9 mRNA, inhibition of p38 kinase prevented the up-regulation of TLR2 and TLR4 mRNA expression but enhanced the up-regulation of TLR9 expression. These results demonstrated that TLR2, TLR4 and TLR9 gene expression was differently regulated by LPS in mouse immature DC. Up-regulation of TLR2, TLR4 and TLR9 expression by LPS might promote the overall responses of DC to bacteria and help to explain the synergy between LPS and other bacterial products in the induction of cytokine production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972630      PMCID: PMC1782697          DOI: 10.1046/j.1365-2567.2002.01401.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages.

Authors:  J J Gao; E G Zuvanich; Q Xue; D L Horn; R Silverstein; D C Morrison
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Presidential Address to The American Association of Immunologists. The road less traveled by: the role of innate immunity in the adaptive immune response.

Authors:  C A Janeway
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

4.  Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin.

Authors:  H Heine; C J Kirschning; E Lien; B G Monks; M Rothe; D T Golenbock
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

5.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Authors:  A Yoshimura; E Lien; R R Ingalls; E Tuomanen; R Dziarski; D Golenbock
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

6.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.

Authors:  S Frantz; L Kobzik; Y D Kim; R Fukazawa; R Medzhitov; R T Lee; R A Kelly
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.

Authors:  X Cao; W Zhang; L He; Z Xie; S Ma; Q Tao; Y Yu; H Hamada; J Wang
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.

Authors:  R B Yang; M R Mark; A Gray; A Huang; M H Xie; M Zhang; A Goddard; W I Wood; A L Gurney; P J Godowski
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Authors:  S T Qureshi; L Larivière; G Leveque; S Clermont; K J Moore; P Gros; D Malo
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  67 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

2.  Legionella pneumophila infection up-regulates dendritic cell Toll-like receptor 2 (TLR2)/TLR4 expression and key maturation markers.

Authors:  James Rogers; Amal Hakki; Izabella Perkins; Catherine Newton; Ray Widen; Nicholas Burdash; Thomas Klein; Herman Friedman
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

Review 3.  Commensal bacteria and epithelial cross talk in the developing intestine.

Authors:  Samuli Rautava; W Allan Walker
Journal:  Curr Gastroenterol Rep       Date:  2007-10

4.  Selective effect of burn injury on splenic CD11c(+) dendritic cells and CD8alpha(+)CD4(-)CD11c(+) dendritic cell subsets.

Authors:  Julie Patenaude; Michele D'Elia; Claudine Hamelin; Jacques Bernier
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

Review 5.  Mucosal vaccines: recent progress in understanding the natural barriers.

Authors:  Olga Borges; Filipa Lebre; Dulce Bento; Gerrit Borchard; Hans E Junginger
Journal:  Pharm Res       Date:  2009-12-01       Impact factor: 4.200

6.  Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

Authors:  Richa Tewari; Saurav Roy Choudhury; Sadashib Ghosh; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2011-09-02       Impact factor: 4.599

7.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

8.  C-reactive protein induces TNF-α secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells.

Authors:  Na Liu; Juntian Liu; Yuanyuan Ji; Peipei Lu; Chenjing Wang; Fang Guo
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

9.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

10.  Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection.

Authors:  Angela Dolganiuc; Catherine Garcia; Karen Kodys; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.